Mubashir J. Mintoo

973 total citations
25 papers, 698 citations indexed

About

Mubashir J. Mintoo is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Mubashir J. Mintoo has authored 25 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Mubashir J. Mintoo's work include Quinazolinone synthesis and applications (6 papers), Synthesis and biological activity (5 papers) and Natural product bioactivities and synthesis (4 papers). Mubashir J. Mintoo is often cited by papers focused on Quinazolinone synthesis and applications (6 papers), Synthesis and biological activity (5 papers) and Natural product bioactivities and synthesis (4 papers). Mubashir J. Mintoo collaborates with scholars based in India, United States and Germany. Mubashir J. Mintoo's co-authors include Dilip M. Mondhe, Prem N. Gupta, Sandip B. Bharate, Dilip M. Mondhe, Ankit Saneja, Ravindra Dhar Dubey, Parduman Raj Sharma, Payare L. Sangwan, Robin Kumar and Santosh Kumar Guru and has published in prestigious journals such as Oncogene, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Mubashir J. Mintoo

25 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mubashir J. Mintoo India 17 354 173 129 88 64 25 698
Anupama Chaudhary India 4 386 1.1× 156 0.9× 179 1.4× 185 2.1× 47 0.7× 7 966
Maria Antonietta Occhiuzzi Italy 16 263 0.7× 148 0.9× 54 0.4× 98 1.1× 47 0.7× 35 653
Neng Qiu China 18 267 0.8× 281 1.6× 169 1.3× 55 0.6× 61 1.0× 39 825
Rupa Sanyal India 7 449 1.3× 166 1.0× 185 1.4× 207 2.4× 57 0.9× 14 1.1k
Venkateswararao Eeda South Korea 13 223 0.6× 208 1.2× 213 1.7× 54 0.6× 91 1.4× 38 705
Surendar Reddy Bathula India 17 481 1.4× 411 2.4× 245 1.9× 75 0.9× 57 0.9× 35 1.1k
Foram U. Vaidya India 15 223 0.6× 160 0.9× 50 0.4× 168 1.9× 29 0.5× 25 577
Katarzyna Wiktorska Poland 16 393 1.1× 202 1.2× 70 0.5× 94 1.1× 34 0.5× 43 702
Bijesh Kumar Biswal India 18 541 1.5× 162 0.9× 67 0.5× 140 1.6× 51 0.8× 49 966

Countries citing papers authored by Mubashir J. Mintoo

Since Specialization
Citations

This map shows the geographic impact of Mubashir J. Mintoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mubashir J. Mintoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mubashir J. Mintoo more than expected).

Fields of papers citing papers by Mubashir J. Mintoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mubashir J. Mintoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mubashir J. Mintoo. The network helps show where Mubashir J. Mintoo may publish in the future.

Co-authorship network of co-authors of Mubashir J. Mintoo

This figure shows the co-authorship network connecting the top 25 collaborators of Mubashir J. Mintoo. A scholar is included among the top collaborators of Mubashir J. Mintoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mubashir J. Mintoo. Mubashir J. Mintoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koide, Akiko, Mubashir J. Mintoo, Matthew J. Sale, et al.. (2024). Inhibition and degradation of NRAS with a pan-NRAS monobody. Oncogene. 43(48). 3489–3497. 3 indexed citations
2.
Khan, Sameer Ullah, Anup S. Pathania, Abubakar Wani, et al.. (2022). Activation of lysosomal mediated cell death in the course of autophagy by mTORC1 inhibitor. Scientific Reports. 12(1). 5052–5052. 11 indexed citations
3.
Mintoo, Mubashir J., Rajesh Kumar, Sandip B. Bharate, et al.. (2022). In vitro and in vivo anticancer potential and molecular targets of the new colchicine analog IIIM-067. Journal of Integrative Medicine. 21(1). 62–76. 8 indexed citations
4.
Kumar, Sushil, et al.. (2022). Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy. Molecular Pharmaceutics. 19(7). 2429–2440. 17 indexed citations
5.
Mintoo, Mubashir J., Sameer Ullah Khan, Abubakar Wani, et al.. (2021). A rohitukine derivative IIIM‐290 induces p53 dependent mitochondrial apoptosis in acute lymphoblastic leukemia cells. Molecular Carcinogenesis. 60(10). 671–683. 16 indexed citations
6.
Kumar, Vikas, Mubashir J. Mintoo, Dilip M. Mondhe, et al.. (2019). Binary and ternary solid dispersions of an anticancer preclinical lead, IIIM-290: In vitro and in vivo studies. International Journal of Pharmaceutics. 570. 118683–118683. 28 indexed citations
7.
Saneja, Ankit, Robin Kumar, Mubashir J. Mintoo, et al.. (2019). Gemcitabine and betulinic acid co-encapsulated PLGA−PEG polymer nanoparticles for improved efficacy of cancer chemotherapy. Materials Science and Engineering C. 98. 764–771. 77 indexed citations
8.
Kumar, Dinesh, Pooja Sharma, Kunal Nepali, et al.. (2018). Antitumour, acute toxicity and molecular modeling studies of 4-(pyridin-4-yl)-6-(thiophen-2-yl) pyrimidin-2(1H)-one against Ehrlich ascites carcinoma and sarcoma-180. Heliyon. 4(6). e00661–e00661. 12 indexed citations
9.
Dash, Ashutosh K., Debasis Nayak, Nazar Hussain, et al.. (2018). Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth. Anti-Cancer Agents in Medicinal Chemistry. 19(2). 276–288. 7 indexed citations
10.
Alam, Noor, Mubashir J. Mintoo, Vaibhav Khare, et al.. (2017). Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor. Biomedicine & Pharmacotherapy. 95. 856–864. 46 indexed citations
11.
Saneja, Ankit, Robin Kumar, Amarinder Singh, et al.. (2017). Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy. International Journal of Pharmaceutics. 531(1). 153–166. 59 indexed citations
12.
Aga, Mushtaq A., Javeed Ahmad Bhat, Brijesh Kumar, et al.. (2017). Exploring Derivatives of Quinazoline Alkaloid l-Vasicine as Cap Groups in the Design and Biological Mechanistic Evaluation of Novel Antitumor Histone Deacetylase Inhibitors. Journal of Medicinal Chemistry. 60(8). 3484–3497. 19 indexed citations
13.
Guru, Santosh Kumar, Sudhakar Manda, Ashok Kumar, et al.. (2017). A marine sponge alkaloid derivative 4-chloro fascaplysin inhibits tumor growth and VEGF mediated angiogenesis by disrupting PI3K/Akt/mTOR signaling cascade. Chemico-Biological Interactions. 275. 47–60. 60 indexed citations
14.
Hussain, Aashiq, Asif Khurshid Qazi, Nagaraju Mupparapu, et al.. (2016). A novel PI3K axis selective molecule exhibits potent tumor inhibition in colorectal carcinogenesis. Molecular Carcinogenesis. 55(12). 2135–2155. 14 indexed citations
15.
Yadav, Rammohan R., Santosh Kumar Guru, Prashant Joshi, et al.. (2016). 6-Aryl substituted 4-(4-cyanomethyl) phenylamino quinazolines as a new class of isoform-selective PI3K-alpha inhibitors. European Journal of Medicinal Chemistry. 122. 731–743. 42 indexed citations
16.
Saneja, Ankit, Love Sharma, Ravindra Dhar Dubey, et al.. (2016). Synthesis, characterization and augmented anticancer potential of PEG-betulinic acid conjugate. Materials Science and Engineering C. 73. 616–626. 36 indexed citations
17.
Kumar, Ashok, Baljinder Singh, Girish Mahajan, et al.. (2016). A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic cancer cells. Tumor Biology. 37(10). 13121–13136. 20 indexed citations
18.
Rasool, Reyaz ur, Bilal Rah, Hina Amin, et al.. (2016). Dual modulation of Ras-Mnk and PI3K-AKT-mTOR pathways: A Novel c-FLIP inhibitory mechanism of 3-AWA mediated translational attenuation through dephosphorylation of eIF4E. Scientific Reports. 6(1). 18800–18800. 19 indexed citations
19.
Singh, Aastha, Kaneez Fatima, Arjun Singh, et al.. (2015). Anticancer activity and toxicity profiles of 2-benzylidene indanone lead molecule. European Journal of Pharmaceutical Sciences. 76. 57–67. 68 indexed citations
20.
Majeed, Rabiya, Payare L. Sangwan, Praveen K. Chinthakindi, et al.. (2014). Inhibition of phosphotidylinositol-3 kinase pathway by a novel naphthol derivative of betulinic acid induces cell cycle arrest and apoptosis in cancer cells of different origin. Cell Death and Disease. 5(10). e1459–e1459. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026